CIR Model For Ingredient Assessment Piques China's Interest
This article was originally published in The Rose Sheet
Executive Summary
Regulatory authorities in developing countries, including China, are showing increasing interest in the Cosmetic Ingredient Review process, with a view to adapting it for use in their own regions, according to CIR Director Lillian Gill.
You may also be interested in...
CIR Director Gill Steps Down, Leaving Legacy Of Improved Transparency
Lillian Gill, director of the Cosmetic Ingredient Review, helped to bolster CIR’s international reputation during her four-year stint leading the group. CIR’s profile has risen as a result of her leadership, openness to outside stakeholder input and increased public interest in cosmetic ingredients’ safety overall.
Congress Proposes Public-Private Partnership For CIR
In reports accompanying draft fiscal 2016 funding bills, both House and Senate committees recommend that FDA work with industry to explore formalizing the Cosmetic Ingredient Review via a public-private partnership similar to that in place with the U.S. Pharmacopeial Convention.
ICCS President Hill On Growing Regulatory Confidence In Alternative Testing Methodologies
In the year since its establishment, the International Collaboration on Cosmetics Safety has worked to engage with regulators as they build frameworks for assessing cosmetic safety without animal tests. ICCS president and CEO Erin Hill discusses current challenges and what lies ahead.